Andy Herbert

Biography

Andy Herbert started work in the biotechnology industry in 1984. After receiving a doctorate in biochemical engineering sponsored by Unilever in the UK, he worked for five years in process development in ICI’s industrial fermentation and biochemicals division. He moved to Canada in 1989 and spent nine years in human vaccine development with Sanofi-Pasteur, ultimately taking responsibility for all vaccine development at the company. He was part of teams that developed and licensed the world’s most effective acellular pertussis vaccine and the world’s first human cancer vaccine (ImmuCyst®, for the treatment of superficial bladder cancer). In 1998 he founded a biopharmaceutical engineering consulting company in Toronto and over the next eight years assisted more than 30 different biotechnology client companies in Canada, USA, Mexico, Cuba and Argentina. After moving to New Zealand in 2005 he took a role as General Manager Operations with ICPbio Ltd., leaving the firm in early 2007 to set up as an independent consultant to biotechnology companies, trading as Bioboy Ltd. Based in Nelson, Andy works with a range of New Zealand and Australian companies including those developing pharmaceuticals, nutraceuticals, food ingredients, new processing technologies and services. He is a member of the organizing committee for the BioProcessing Network, a group of bioprocess specialists based in Australia who seek to find ways to share knowledge and expertise within the biotechnical community.

Research Interest

biotechnology